Healthy plant-based diets cut mortality risks for Spain’s seniors

A study spanning 12 years reveals that moderate adherence to a healthful pro-vegetarian diet significantly reduces mortality risks from cardiovascular disease and all causes among Spanish adults over 65.

Mesoblast wins long-awaited approval for cell therapy

Mesoblast’s stock surged on Thursday after the company won FDA approval for its twice-rejected graft-versus-host disease therapy. Remestemcel-L is the first mesenchymal stromal cell therapy

December 20, 2024

Cano Health’s downfall offers a warning for Medicare Advantage

Private Medicare just isn’t the gold mine it once was. Case in point: Cano Health, a company once valued at $4.4 billion, is now bankrupt.

February 5, 2024

To Get More New Antimicrobial Drugs, Fix the Broken Market, Experts Say

Fixing the broken market for innovative antimicrobial drugs should start with the hospitals, said Christine Ann Miller, MBA, at the Future of Health Summit sponsored

November 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.